tykhr
sign in
free sign up
Terns Pharmaceuticals Inc
Biotechnology
Healthcare
TERN
77.82 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.00
52 week high
11.23
high
2.43
52 week low
2.00
low
1.94
growth
-61.73 %
previous Close
2.05
P/E ratio
market cap
490 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-21.95 M
3.48 %
eps
0.00 %
9.68 %
eps surprise
12.50 %
net profit margin
-2194500000.00 %
0.00 %
operating incoming
-24.94 M
2.34 %
net change in cash
179 M
576.74 %
cash on hand
270 M
195.24 %
cost of revenue
0.00 %
top